glutathione pathway to triple negative cancer GPX4 in triple-negative breast cancer: A key regulator of ferroptosis and therapeutic target Activation of the eIF2α/ATF4 axis
Activation of the eIF2 ATF4 axis drives triple negative breast cancer radioresistance by promoting glutathione biosynthesis ScienceDirect Role of Glutathione in Cancer: From Mechanisms to Therapies Glutathione Dependent Pathways in Cancer Cells Ferroptosis heterogeneity in triple negative breast cancer reveals an innovative immunotherapy combination strategy ScienceDirect
Pay in 4 interest-free payments of $6.41 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8



